|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Stock-based compensation | |||||
| Depreciation and amortization | |||||
| Amortization of debt issuance costs | |||||
| Change in fair value of warrant liability | |||||
| Accretion of marketable securities purchased at a discount | |||||
| Other non-cash items | |||||
| Change in operating assets and liabilities: | |||||
| Inventories | |||||
| Other current and non-current assets | |||||
| Accounts payable and accrued liabilities | |||||
| Accounts payable | |||||
| Customer deposits | |||||
| Other current and non-current liabilities | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities: | |||||
| Capital expenditures | |||||
| Purchases of marketable securities | |||||
| Proceeds from maturities and calls of marketable securities | |||||
| Other investing activities | |||||
| Net cash provided by investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from issuance of long-term debt | |||||
| Repurchase of convertible debt | |||||
| Debt issuance costs | |||||
| Purchase of capped call | |||||
| Repayment of commercial loan | |||||
| Payments of finance lease obligations | |||||
| Proceeds from convertible senior notes | |||||
| Proceeds from issuance of common stock pursuant to at-the-market offering | |||||
| At The Market Offering | |||||
| Registered Offering | |||||
| Total proceeds from issuance of common stock pursuant to at-the-market offering | |||||
| Proceeds from issuance of common stock pursuant to stock options exercised | |||||
| Proceeds from issuance of Purchase Warrants | |||||
| Proceeds from issuance of common stock pursuant to ESPP | |||||
| Withholding taxes paid on behalf of employees on net settled stock-based awards | |||||
| Other financing activities | |||||
| Net cash provided by financing activities | |||||
| Net decrease in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash at beginning of year | |||||
| Cash, cash equivalents and restricted cash at end of year | |||||
| Cash and cash equivalents | |||||
| Restricted cash | |||||
Loading...